The Enterprise Value as of December 2025 (TTM) for China Resources Double-Crane Pharmaceutical Co.,Ltd. (600062.SS) is 18.14B

According to China Resources Double-Crane Pharmaceutical Co.,Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 18.14B. This represents a change of -0.98% compared to the average of 18.32B of the last 4 quarters.

China Resources Double-Crane Pharmaceutical Co.,Ltd. (600062.SS) Historical Enterprise Value (quarterly & annually)

How has 600062.SS Enterprise Value performed in the past?

The mean historical Enterprise Value of China Resources Double-Crane Pharmaceutical Co.,Ltd. over the last ten years is 14.52B. The current 18.14B Enterprise Value has changed 12.39% with respect to the historical average. Over the past ten years (40 quarters), 600062.SS's Enterprise Value was at its highest in in the September 2024 quarter at 22.51B. The Enterprise Value was at its lowest in in the March 2021 quarter at 9.71B.

China Resources Double-Crane Pharmaceutical Co.,Ltd. (600062.SS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of China Resources Double-Crane Pharmaceutical Co.,Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

China Resources Double-Crane Pharmaceutical Co.,Ltd. (600062.SS) Average Enterprise Value

How has 600062.SS Enterprise Value performed in the past?

The current Enterprise Value of China Resources Double-Crane Pharmaceutical Co.,Ltd. (600062.SS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

China Resources Double-Crane Pharmaceutical Co.,Ltd. (600062.SS) Enterprise Value vs. Peers

How is 600062.SS’s Enterprise Value compared to its peers?

China Resources Double-Crane Pharmaceutical Co.,Ltd.’s Enterprise Value is greater than China National Medicines Corporation Ltd. (16.74B), greater than Joincare Pharmaceutical Group Industry Co.,Ltd. (14.20B), less than Hubei Jumpcan Pharmaceutical Co., Ltd. (21.35B), greater than Apeloa Pharmaceutical Co.,Ltd (17.95B), greater than Zhejiang Jiuzhou Pharmaceutical Co., Ltd (13.73B), greater than Walvax Biotechnology Co., Ltd. (16.69B), less than Hybio Pharmaceutical Co., Ltd. (18.55B), less than Tasly Pharmaceutical Group Co., Ltd (21.14B), greater than Shenzhen Kangtai Biological Products Co., Ltd. (17.92B), greater than Fujian Cosunter Pharmaceutical Co., Ltd. (14.60B),

Build a custom stock screener for China Resources Double-Crane Pharmaceutical Co.,Ltd. (600062.SS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like China Resources Double-Crane Pharmaceutical Co.,Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

China Resources Double-Crane Pharmaceutical Co.,Ltd. (600062.SS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like China Resources Double-Crane Pharmaceutical Co.,Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.